Work

Sunitinib as First-line Treatment for Metastatic Renal Cell Carcinoma (mrcc): Updated Results and Analysis of Prognostic Factors From a Phase Iii Randomised Trial

Year: 2008

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(08)60696-x

Authors: S. Oudard, R.J. Motzer, M.D. Michaelson, T.E. Hutson, P. Tomczak, R.M. Bukowski, O. Rixie, S. Negrier, S.T. Kim, I. Chen, R.A. Figlin

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2095375648

Cites:

Cited by: 4

Related to: 10